Finland · Delayed Price · Currency is EUR Detection Technology Oyj Earnings Call Transcripts
Fiscal Year 2026
-
Q2 saw 5.1% sales growth to EUR 25.6 million, led by medical and TFT segments, while China weighed on security and industrial sales. Investments focused on R&D and capacity, with strong order backlog and growth expected in H2, especially in medical and industrial.
Fiscal Year 2025
-
Q4 sales declined 6% year-over-year, mainly due to FX, with strong medical growth offset by declines in security and industrial. Double-digit sales growth is guided for Q1 and H1, driven by volume increases across all segments, while margins remain under pressure from product mix and competition.
-
The 2030 strategy targets 10% annual growth by expanding TFT flat panel detectors, leveraging a full in-house technology portfolio, and focusing on customer-centric innovation. Growth is expected across medical, security, and industrial markets, with a strong presence in APAC and new manufacturing in India.
-
Sales declined 7% in Q2, mainly due to forex and regulatory delays, but market position held firm. Industrial and medical segments grew, while security and EMEA sales dropped sharply. Outlook calls for single-digit sales decline in H2, with recovery in security expected next year.
Fiscal Year 2024
-
Q4 and full-year results showed modest sales growth, improved EBITDA margins, and strong cash flow. Security led segment performance, while medical stabilized and industrial grew. Outlook for 2024 is flat Q1, followed by double-digit growth, with risks from price competition and tariffs.
-
Q2 net sales grew 3.5% year-over-year to EUR 26.1 million, with EBIT margin improving to 12.7%. Security and industrial segments drove growth, while medical sales lagged due to China reforms. Double-digit growth is expected for Q3 and H2.